You are here

  • Home
  • Archive
  • Volume 11, Issue 6
  • Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial

 

Online download statistics by month:

Online download statistics by month: June 2023 to March 2026

AbstractFullPdf
Jun 202354553
Jul 2023582584278
Aug 2023321323108
Sep 202317117197
Oct 202314714858
Nov 202315415557
Dec 202311912083
Jan 2024137139110
Feb 202410010064
Mar 2024127130111
Apr 2024131131103
May 202411111186
Jun 2024868678
Jul 202410911071
Aug 2024767566
Sep 202410411590
Oct 2024113114104
Nov 2024131134106
Dec 202410410673
Jan 2025989987
Feb 2025132133121
Mar 2025128128103
Apr 2025143145105
May 2025118119101
Jun 2025768154
Jul 2025110
Mar 2026110
Total357436142317